Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

25-SMI-2014 is a post market observational, questionnaire based study to assess the effectiveness of the Axium neurostimulator as a treatment for chronic post surgical groin pain. Within is also a nested feasibility study to assess the clinical utility of a Quantitive Sensory Testing (QST) protocol in the management of the described study group.

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT02346656` - a BavaRiAn eValuatiOn of Dorsal Root Ganglion (DRG) Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin

NCT number	NCT02337699
Study type	Observational
Source	Abbott Medical Devices
Contact
Status	Terminated
Phase
Start date	January 2015
Completion date	September 2015

Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — GASPA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms